Molecules/ELRANATAMAB

ELRANATAMAB

Molecular Identity

AntibodyApprovedFirst approved 2023

Mechanism of action: T cell surface glycoprotein CD3 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

ELRANATAMABELRANATAMAB-BCMMELREXFIOPF-06863135RN-613RN613

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to ELRANATAMAB

Loading drug network...